A Triphenylphosphonium-Functionalized Delivery System for an ATM Kinase Inhibitor That Ameliorates Doxorubicin Resistance in Breast Carcinoma Mammospheres
Venturina Stagni(Institute of Molecular Biology and Pathology), Dimitris Tsiourvas(National Centre of Scientific Research "Demokritos")
Cited by 8